通过外围神经刺激途径治疗血管认知障碍的针治疗:一个范围审查
Xinming Yang1,2, Bo Li1,2,3, Linna Wu4
1First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Frontiers in aging neuroscience
|May 13, 2025
概括
针刺激外周神经对中枢神经系统产生影响,为血管认知障碍 (VCI) 提供了一种新的治疗方法. 这种方法可以增强大脑功能和神经可塑性,改善认知结果.
科学领域:
- 神经科学是一个神经科学.
- 综合医学是一个整体的医学.
- 血管生物学 血管生物学
背景情况:
- 血管认知障碍 (VCI) 在神经健康方面是一个重大挑战.
- 目前对VCI的治疗有局限性,需要探索替代治疗策略.
- 针通过外周刺激调节中枢神经系统功能的潜力是一个越来越感兴趣的领域.
研究的目的:
- 通过外围神经刺激,探索针对血管认知障碍 (VCI) 的核心影响.
- 系统地审查有关VCI针干预的现有文献.
- 阐明针对VCI的治疗作用所涉及的神经通路.
主要方法:
- 一种符合Arksey和O'Malley以及PRISMA-ScR指导方针的范围审查方法.
- 在PubMed,Web of Science,MEDLINE和Embase数据库中进行全面的文献搜索.
- 分析了79项研究,重点关注针点,外围神经解剖学和拟议的神经通路.
主要成果:
- 针可以刺激周围神经 (例如,迷走神经,三角神经) 和神经 (宫,腰部,阴道).
- 刺激增强大脑血流调节,调节神经免疫反应,改善大脑功能.
- 观察到的效果包括促进神经可塑性,最终改善VCI的认知功能.
结论:
- 针通过对外围神经刺激来影响中枢神经系统,用于VCI治疗.
- 了解针诱导的神经反射可以改进VCI疗法.
- 对这些机制的进一步研究可以澄清针疗效的科学基础.
更多相关视频
05:34A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
Published on: November 22, 2024
323
05:54Author Spotlight: Exploring Acupuncture in Alzheimer's Research from Thread-Embedding Techniques to Clinical Trials
Published on: May 10, 2024
532
相关概念视频
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
86
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
86
01:22Alzheimer's Disease: Treatment
133
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
133